Company intelligence / Profile preview

Auxilto

Frankfurt am Main, Hessen, Germanyauxilto.com ↗

Ownership: Private
Development stage: Other

Overview

Auxilto is an international healthcare/pharmaceutical investment and licensing group with operations spanning Europe and Asia. It focuses on providing high-quality medicines at affordable prices through licensing, manufacturing partnerships, trading of APIs/pharmaceuticals, M&A activities, as well as supporting innovative therapies such as CAR-T cell therapy through its affiliated companies. The Czech subsidiary began product launches in 2021 with plans for portfolio expansion into major therapeutic areas like diabetology and cardiology by 2022. No specific clinical trial results are disclosed.

Therapeutic areas: OncologyEndocrinologyCardiovascularNeurology
Modalities: Small moleculeBiologicCell therapy
Industry: Biotech

Partnerships

Stellapharm J.V.Co., Ltd.: leading Vietnamese pharmaceutical manufacturer partnered for manufacturing/licensing/exporting EU-standard pharmaceuticals.

Beyond the preview

Go deeper on Auxilto.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Auxilto.

Explore the full profile